{"id":"https://openalex.org/W7204701626","doi":"https://doi.org/10.1016/s2152-2650(26)02149-x","title":"CML-165: Updates in Diagnosis and Management of Patients With Chronic Phase of Chronic Myeloid Leukemia","display_name":"CML-165: Updates in Diagnosis and Management of Patients With Chronic Phase of Chronic Myeloid Leukemia","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204701626","doi":"https://doi.org/10.1016/s2152-2650(26)02149-x"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02149-x","doi":"https://doi.org/10.1016/s2152-2650(26)02149-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02149-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029259350","display_name":"Vasile Musteata","orcid":"https://orcid.org/0000-0002-9471-7170","observed_orcids":["https://orcid.org/0000-0002-9471-7170"]},"institutions":[{"id":"https://openalex.org/I4210124354","display_name":"Nicolae Testemi\u021banu State University of Medicine and Pharmacy","ror":"https://ror.org/03xww6m08","country_code":"MD","type":"education","lineage":["https://openalex.org/I4210124354"]}],"countries":["MD"],"is_corresponding":true,"raw_author_name":"Vasile Musteata","raw_affiliation_strings":["Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova (the Republic of) Institute of Oncology, Chisinau, Moldova (the Republic of)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova (the Republic of) Institute of Oncology, Chisinau, Moldova (the Republic of)","institution_ids":["https://openalex.org/I4210124354"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5029259350"],"corresponding_institution_ids":["https://openalex.org/I4210124354"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S667","last_page":"S667"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.8309999704360962},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.906000018119812},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.9649999737739563},{"id":"https://openalex.org/keywords/bcr-abl1-transcript","display_name":"BCR-ABL transcript","score":0.8949999809265137},{"id":"https://openalex.org/keywords/b3a2-transcript","display_name":"b3a2 transcript","score":0.7570000290870667},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4580000042915344},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6520000100135803},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.46700000762939453},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6460000276565552},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.5049999952316284},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9190000295639038},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.982200026512146},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6840999722480774},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6733999848365784},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6021000146865845},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.31690001487731934},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.29179999232292175},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.25099998712539673},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2502000033855438},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.23309999704360962}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02149-x","doi":"https://doi.org/10.1016/s2152-2650(26)02149-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02149-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414211505","https://openalex.org/W1836539244","https://openalex.org/W7037043769","https://openalex.org/W3181122946","https://openalex.org/W3196643062","https://openalex.org/W4386102497","https://openalex.org/W6888568640","https://openalex.org/W4281382826","https://openalex.org/W3131755082","https://openalex.org/W7108459141"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}